首页 > 市场调查报告书 > 医疗设备

体外诊断

欧洲凝血市场预测至 2030 年 - 区域分析 - 按疾病适应症、类型、产品、技术和最终用户

市场调查报告书

商品编码

1494295

欧洲凝血市场预测至 2030 年 - 区域分析 - 按疾病适应症、类型、产品、技术和最终用户

Europe Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 116 Pages | 订单完成后即时交付

价格

简介目录图表

2022年欧洲凝血市场价值为200064万美元，预计2030年将达337971万美元；预计2022年至2030年复合年增长率为6.8%。

心血管疾病盛行率上升推动欧洲凝血市场

心臟病是心房颤动和中风等疾病导致住院、死亡和身体机能下降的主要原因之一。它影响止血系统、血管系统和血液的流体动力学，并导致动脉和静脉血栓形成。血栓形成是心血管疾病死亡和併发症的主要原因。因吸烟和高血压而受损的血管会在血管内壁形成富含胆固醇的斑块，这些斑块会破裂并导致血小板凝结。凝血障碍有心肌梗塞、中风和血管床动脉粥状硬化血栓事件的风险。心臟衰竭（HF）与血栓栓塞风险增加有关，与心房颤动（AF）的存在无关。血小板活化和凝血系统异常会增加心臟衰竭患者发生严重血栓栓塞事件的风险。

凝血测试有助于预防潜在的心臟病发作引起的血液凝固。在冠状动脉绕道手术和血管成形术期间使用凝血分析仪来监测凝血状态的资讯。因此，心血管疾病发生率的上升促进了凝血市场的成长。

欧洲混凝市场概况

欧洲凝血市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。欧洲在全球凝血市场中占有重要地位，预计 2022 年至 2030 年复合年增长率将强劲。该地区的市场成长主要归因于心血管疾病发病率的上升、医疗设备的不断进步、人口老化的加剧以及凝血分析仪意识的提高。

德国有很多人患有心血管疾病，这可归因于该国人口老化的加剧。心臟病发作是冠状动脉心臟病（CHD）最严重的后果。迄今为止，超过 360 万德国人被诊断出患有先心病，超过 130 万名中风患者存活。根据世界卫生组织2020年公布的最新资料，德国因冠心病导致的死亡人数达147,055人（占总死亡人数的20.98%）。

欧洲凝血市场收入及 2030 年预测（百万美元）

欧洲混凝市场细分

欧洲凝血市场根据疾病适应症、类型、产品、技术、最终用户和国家进行细分。

根据疾病适应症，欧洲凝血市场分为维生素 K 缺乏症、肝病、瀰漫性血管内凝血及肺栓塞、循环抗凝血剂的发展、血友病、冯维勒布兰氏症等。 2022 年，肝病领域占据欧洲凝血市场最大份额。

根据类型，欧洲凝血市场分为临床实验室分析仪和即时检测分析仪。 2022 年，临床实验室分析仪细分市场将占据更大的欧洲凝血市场份额。等。

在产品方面，欧洲凝血市场分为诊断和治疗。至2022年，诊断细分市场将占据更大的欧洲凝血市场份额。 D-二聚体测试、血小板功能测试等。治疗部分进一步细分为抗纤溶药物、避孕药、去氨加压素和免疫抑制药物、维生素K 补充剂、血液稀释剂、凝血酶抑制剂或血栓溶解剂、替代疗法、导管辅助血栓清除等。

依技术划分，欧洲凝血市场分为光学技术、机械技术、电化学技术等。到 2022 年，光学技术领域将占据欧洲凝血市场最大份额。

依最终用户划分，欧洲凝血市场分为临床实验室、医院等。到 2022 年，医院细分市场将占据欧洲最大的凝血市场。

根据国家/地区，欧洲凝固市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲凝固市场占据主导地位。

F.霍夫曼-拉罗氏有限公司；根瑞生物科技有限公司；堀场有限公司； ImproGen Diagnostik Kimya San。＆抽动。有限公司；西门子医疗集团；希森美康公司；泛亚生物医疗有限公司；和 Nordic Biomarker AB 是欧洲凝血市场上的一些领先公司。

Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.

A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.

Europe Coagulation Market Overview

The Europe coagulation market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe holds a significant position in the global coagulation market and is estimated to register a robust CAGR during 2022-2030. Market growth in this region is mainly attributed to the rising incidence of cardiovascular disorders, increasing advancements in medical devices, the growing aging population, and the surging awareness of coagulation analyzers.

A large number of people in Germany are suffering from cardiovascular disorders, which can be attributed to the growing aging population in the country. Heart attack is the most serious consequence of coronary heart disease (CHD). More than 3.6 million of the German population have been diagnosed with CHD till date, and over 1.3 million have survived a stroke. According to the latest WHO data published in 2020, the count of deaths caused by CHD in Germany reached 147,055 (i.e., 20.98% of total deaths).

Europe Coagulation Market Revenue and Forecast to 2030 (US$ Million)

Europe Coagulation Market Segmentation

The Europe coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the Europe coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest Europe coagulation market share in 2022.

Based on type, the Europe coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Europe coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Europe coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Europe coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Europe coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Europe coagulation market share in 2022.

By end user, the Europe coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Europe coagulation market share in 2022.

Based on country, the Europe coagulation market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe coagulation market in 2022.

F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.; Siemens Healthineers AG; Sysmex Corp; Transasia Bio-Medicals Ltd; and Nordic Biomarker AB are some of the leading companies operating in the Europe coagulation market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Coagulation Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Blood Disorders
- 4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
- 4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
- 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
- 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis

5. Coagulation Market - Europe Market Analysis

5.1 Europe Coagulation Market Revenue (US$ million), 2022 - 2030

6. Europe Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

6.1 Overview
6.2 Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
- 6.3.1 Overview
- 6.3.2 Vitamin K Deficiency: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
- 6.4.1 Overview
- 6.4.2 Liver Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 6.5.1 Overview
- 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
- 6.6.1 Overview
- 6.6.2 Development of Circulating Anticoagulant: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
- 6.7.1 Overview
- 6.7.2 Hemophilia: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand's Disease
- 6.8.1 Overview
- 6.8.2 Von Willebrand's Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.9 Others
- 6.9.1 Overview
- 6.9.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Coagulation Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
- 7.3.1 Overview
- 7.3.2 Clinical Laboratory Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
- 7.4.1 Overview
- 7.4.2 Point-of-Care Testing Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Coagulation Market - Revenue and Forecast to 2030 - by Offering

8.1 Overview
8.2 Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
- 8.3.1 Overview
- 8.3.2 Diagnosis: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Europe Coagulation Market, by Diagnosis
8.4 Treatment
- 8.4.1 Overview
- 8.4.2 Treatment: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Europe Coagulation Market, by Treatment

9. Europe Coagulation Market - Revenue and Forecast to 2030 - by Technology

9.1 Overview
9.2 Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
- 9.3.1 Overview
- 9.3.2 Optical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
- 9.4.1 Overview
- 9.4.2 Mechanical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
- 9.5.1 Overview
- 9.5.2 Electrochemical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Coagulation Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
- 10.3.1 Overview
- 10.3.2 Clinical Laboratories: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
- 10.4.1 Overview
- 10.4.2 Hospitals: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Coagulation Market - Country Analysis

11.1 Europe Coagulation Market, Revenue and Forecast to 2030
- 11.1.1 Europe Coagulation Market by Country
  - 11.1.1.1 Germany
    - 11.1.1.1.1 Overview
    - 11.1.1.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.1.3 Germany Coagulation Market, by Disease Indication
    - 11.1.1.1.4 Germany Coagulation Market, by Type
    - 11.1.1.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.1.5 Germany Coagulation Market, by Offering
    - 11.1.1.1.5.1 Germany Coagulation Market, by Diagnosis
    - 11.1.1.1.5.2 Germany Coagulation Market, by Treatment
    - 11.1.1.1.6 Germany Coagulation Market, by Technology
    - 11.1.1.1.7 Germany Coagulation Market, by End User
  - 11.1.1.2 UK
    - 11.1.1.2.1 Overview
    - 11.1.1.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.2.2 UK Coagulation Market, by Disease Indication
    - 11.1.1.2.3 UK Coagulation Market, by Type
    - 11.1.1.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.2.4 UK Coagulation Market, by Offering
    - 11.1.1.2.4.1 UK Coagulation Market, by Diagnosis
    - 11.1.1.2.4.2 UK Coagulation Market, by Treatment
    - 11.1.1.2.5 UK Coagulation Market, by Technology
    - 11.1.1.2.6 UK Coagulation Market, by End User
  - 11.1.1.3 France
    - 11.1.1.3.1 Overview
    - 11.1.1.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.3.2 France Coagulation Market, by Disease Indication
    - 11.1.1.3.3 France Coagulation Market, by Type
    - 11.1.1.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.3.4 France Coagulation Market, by Offering
    - 11.1.1.3.4.1 France Coagulation Market, by Diagnosis
    - 11.1.1.3.4.2 France Coagulation Market, by Treatment
    - 11.1.1.3.5 France Coagulation Market, by Technology
    - 11.1.1.3.6 France Coagulation Market, by End User
  - 11.1.1.4 Italy
    - 11.1.1.4.1 Overview
    - 11.1.1.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.4.2 Italy Coagulation Market, by Disease Indication
    - 11.1.1.4.3 Italy Coagulation Market, by Type
    - 11.1.1.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.4.4 Italy Coagulation Market, by Offering
    - 11.1.1.4.4.1 Italy Coagulation Market, by Diagnosis
    - 11.1.1.4.4.2 Italy Coagulation Market, by Treatment
    - 11.1.1.4.5 Italy Coagulation Market, by Technology
    - 11.1.1.4.6 Italy Coagulation Market, by End User
  - 11.1.1.5 Spain
    - 11.1.1.5.1 Overview
    - 11.1.1.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.5.3 Spain Coagulation Market, by Disease Indication
    - 11.1.1.5.4 Spain Coagulation Market, by Type
    - 11.1.1.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.5.5 Spain Coagulation Market, by Offering
    - 11.1.1.5.5.1 Spain Coagulation Market, by Diagnosis
    - 11.1.1.5.5.2 Spain Coagulation Market, by Treatment
    - 11.1.1.5.6 Spain Coagulation Market, by Technology
    - 11.1.1.5.7 Spain Coagulation Market, by End User
  - 11.1.1.6 Rest of Europe
    - 11.1.1.6.1 Overview
    - 11.1.1.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.6.3 Rest of Europe Coagulation Market, by Disease Indication
    - 11.1.1.6.4 Rest of Europe Coagulation Market, by Type
    - 11.1.1.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.6.5 Rest of Europe Coagulation Market, by Offering
    - 11.1.1.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
    - 11.1.1.6.5.2 Rest of Europe Coagulation Market, by Treatment
    - 11.1.1.6.6 Rest of Europe Coagulation Market, by Technology
    - 11.1.1.6.7 Rest of Europe Coagulation Market, by End User

12. Europe Coagulation Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Siemens Healthineers AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Nordic Biomarker AB
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Sysmex Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Genrui Biotech Co., Ltd.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Transasia Bio-Medicals Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Horiba Ltd.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Coagulation Market Segmentation
Table 2. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 3. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 4. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 8. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 9. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 10. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 11. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 12. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 13. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 14. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 15. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 16. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 17. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 18. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 19. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 20. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 21. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 22. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 23. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 24. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 25. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 26. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 27. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 28. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 29. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 30. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 31. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 32. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 34. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 35. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 36. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 37. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 38. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 39. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 40. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 41. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 42. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 43. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 44. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 45. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 46. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 47. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 48. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 49. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 50. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 51. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 52. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 53. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 54. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 55. Recent Inorganic Growth Strategies in the Coagulation Market
Table 56. Recent Organic Growth Strategies in the Coagulation Market
Table 57. Glossary of Terms, Coagulation Market

List Of Figures

Figure 1. Europe Coagulation Market Segmentation, By Country
Figure 2. Europe Coagulation Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Coagulation Market Revenue (US$ million), 2020 - 2030
Figure 5. Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand's Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Europe Coagulation Market, By Geography, 2022 ($million)
Figure 29. Europe Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. France Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 34. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 35. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 36. Growth Strategies in the Coagulation Market